Comments
Dr Reddy's Laboratories shares rose as much as 1.9 per cent to hit a 52-week high of Rs 3,287.10 in morning trade today.
The company said it has launched memantine hydrochloride tablets, a copy of Actavis Plc Alzheimer's drug Namenda, in the United States. The drug has a market size of $1.4 billion in United States as per IMS Health and will have about 10 players competing, according to analysts.
"We expect Dr Reddy's to garner revenues of $10-$15 million upon launch," analyst Sapna Jhawar at Reliance Securities wrote in a note.
Dr Reddy’s shares were trading at Rs 3,804.50, up Rs 45.75 or 1.22 per cent on the BSE at about 11 am.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.